Guided Therapeutics, Inc. Share Price
Equities
GTHP
US40171F5017
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.09 USD | +5.88% | -17.43% | -41.37% |
Sales 2022 | 13K 1.04M | Sales 2023 | 98K 7.85M | Capitalization | 8.31M 666M |
---|---|---|---|---|---|
Net income 2022 | -4M -321M | Net income 2023 | -3M -240M | EV / Sales 2022 | 1,118 x |
Net cash position 2022 | 50K 4.01M | Net Debt 2023 | 1.47M 118M | EV / Sales 2023 | 99.7 x |
P/E ratio 2022 |
-1.96
x | P/E ratio 2023 |
-2.09
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 56.2% |
1 day | +5.88% | ||
1 week | -17.43% | ||
Current month | -17.43% | ||
1 month | -18.92% | ||
3 months | -49.94% | ||
6 months | -40.00% | ||
Current year | -41.37% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 68 | 26/10/92 |
Founder | 68 | 26/10/92 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Imhoff
BRD | Director/Board Member | 74 | 09/04/06 |
Richard Blumberg
BRD | Director/Board Member | 67 | 09/11/16 |
Mark Faupel
CEO | Chief Executive Officer | 68 | 26/10/92 |
Date | Price | Change | Volume |
---|---|---|---|
07/05/24 | 0.09 | +5.88% | 52,301 |
06/05/24 | 0.085 | -15.00% | 81,619 |
03/05/24 | 0.1 | +14.81% | 27,110 |
02/05/24 | 0.0871 | -20.09% | 108 |
Delayed Quote OTC Markets, May 07, 2024 at 07:19 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-41.37% | 5.02M | |
+7.93% | 219B | |
+7.53% | 184B | |
+15.20% | 138B | |
-1.14% | 62.54B | |
+7.23% | 52.22B | |
+12.58% | 51.73B | |
+1.61% | 41.4B | |
+5.32% | 37.17B | |
+25.66% | 31.76B |
- Stock Market
- Equities
- GTHP Stock